Promacta and Promethazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promacta (eltrombopag olamine) and Promethazine (promethazine hydrochloride). Common drug interactions include death among females and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Promacta and Promethazine. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Promacta?

Promacta has active ingredients of eltrombopag olamine. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,758 Promacta users. Check the latest studies of Promacta.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.



On Jul, 12, 2026

26 people who take Promacta and Promethazine together, and have interactions are studied.

Promacta and Promethazine drug interactions.

What are the common drug interactions of Promacta and Promethazine, by gender? *:

female:

  1. Death
  2. Diarrhoea
  3. Epigastric discomfort
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Anaemia (lack of blood)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Headache (pain in head)
  8. Subdural haematoma (blood collects between the skull and the surface of the brain)
  9. Asthenia (weakness)
  10. Bone disorder

male:

  1. Platelet count decreased
  2. Abdominal pain
  3. Abasia (inability to walk)
  4. Anger
  5. Aphagia (inability or refusal to swallow)
  6. Asthenia (weakness)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Bone pain
  9. Cellulitis (infection under the skin)
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the common drug interactions of Promacta and Promethazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood bilirubin increased
  4. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  5. Gamma-glutamyltransferase increased

30-39:

n/a

40-49:

  1. Subdural haematoma (blood collects between the skull and the surface of the brain)
  2. Asthenia (weakness)
  3. Fall
  4. Rib fracture
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Urinary tract infection
  7. Head injury
  8. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  9. Loss of consciousness

50-59:

  1. Abdominal pain
  2. Dizziness
  3. Fatigue (feeling of tiredness)
  4. Gastric disorder (disease of stomach)
  5. Hepatic pain (pain in liver)
  6. Loss of consciousness
  7. Platelet count decreased
  8. Bone density decreased
  9. Feeding disorder (when children refuse to eat certain food groups)
  10. Activities of daily living impaired

60+:

  1. Anaemia (lack of blood)
  2. Death
  3. Anaemia macrocytic (a macrocytic class of anaemia)
  4. Chronic myelomonocytic leukaemia (cancers of the blood-forming cells of the bone marrow)
  5. Fatigue (feeling of tiredness)
  6. Haemorrhage (bleeding)
  7. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  8. Leukaemia (blood or bone marrow cancer)
  9. Leukocytosis (increased white blood cells)
  10. Pallor

What are the existing conditions these people have? *

  1. Hepatitis C: 4 people, 15.38%
  2. Back Pain: 3 people, 11.54%
  3. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 7.69%
  4. Joint Pain: 2 people, 7.69%
  5. Insomnia (sleeplessness): 2 people, 7.69%
  6. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 7.69%
  7. Aplastic Anemia: 2 people, 7.69%
  8. Adverse Event: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Promacta and Promethazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promacta and Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promacta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promacta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on eltrombopag olamine and promethazine hydrochloride (the active ingredients of Promacta and Promethazine, respectively), and Promacta and Promethazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: